| Autor: |
Jagadeesh, Menon, Ashwin, Rammohan, Mukul, Vij, Naresh, Shanmugam, Mohamed, Rela |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
World Journal of Gastroenterology. 28:4044-4052 |
| ISSN: |
1007-9327 |
| DOI: |
10.3748/wjg.v28.i30.4044 |
| Popis: |
Langerhans cell histiocytosis (LCH) is a malignant disease of the histiocytes involving various organ systems. The spectrum of liver involvement in LCH ranges from mild transaminitis to end-stage liver disease. The hallmark of hepatic LCH is secondary sclerosing cholangitis, which manifests due to a progressive destruction of the biliary tree by malignant histiocytes. Chemotherapy remains the mainstay of treatment for active LCH. Early recognition, diagnosis and a systematic approach to the management of LCH can ameliorate the disease process. Nonetheless, the liver involvement in these patients may progress despite the LCH being in remission. Liver transplantation (LT) remains central in the management of such patients. Various facets of the management of LCH, especially those with liver involvement remain unclear. Furthermore, aspects of LT in LCH with regards to the indication, timing and post-LT management, including immunosuppression and adjuvant therapy, remain undefined. This review summarises the current evidence and discusses the practical aspects of the role of LT in the management of LCH. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
